Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 21 · below the Ichimoku cloud · RSI 31 · MACD above its signal · 6% above its 52-week low
None of the 29 investors followed here reported a position in ISPC in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ISPC trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for ISPC.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 35.0 | -28.8 | -37.2 | -16.7 | -39.6 | -16.1 | -28.7 | -18.5 | -23.4 | -8.5 | −89.6% | ||
| 2025 | -25.0 | -16.6 | -36.1 | 19.8 | -3.9 | -19.7 | 26.5 | -42.7 | 81.4 | -39.5 | -46.2 | -38.1 | −90.2% |
| 2024 | -3.8 | -6.6 | -48.4 | 25.4 | 47.8 | -28.1 | -14.2 | 1.9 | -13.0 | -8.9 | 0.2 | -38.1 | −73.5% |
| 2023 | 22.9 | -3.6 | -17.8 | 15.8 | -14.3 | 7.5 | 7.7 | -43.5 | -28.7 | -8.1 | -1.8 | -10.5 | −63.6% |
| 2022 | -37.4 | -16.0 | 30.7 | -40.6 | -6.0 | -27.3 | 7.8 | -6.8 | -24.7 | -3.6 | -1.3 | -12.4 | −82.4% |
| 2021 | -13.0 | 8.1 | -14.1 | 28.7 | 145.9 | -57.7 | +8.2% |
No analyst coverage for this instrument.
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.